Spinal Muscular Atrophy drug: regulatory approval should guide Kerala’s procurement policy, say experts

Experts urge Kerala to adopt a cost-effective procurement policy for Spinal Muscular Atrophy drugs, prioritizing approved generics over high-priced patents.

Raccontata dathehindu.com